Daiwa Securities Group Inc. Incyte Corp Transaction History

Daiwa Securities Group Inc.

$17.7 Billion
Q1 2024

A detailed history of Daiwa Securities Group Inc. transactions in Incyte Corp stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 32,957 shares of INCY stock, worth $1.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

32,957

Previous 23,064 42.89%

Holding current value

$1.89 Million

Previous $1.45 Million 29.7%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$56.55 - $66.59 $559,449 - $658,774	9,893 Added 42.89%	32,957 $1.88 Million
Q4 2023 Jan 31, 2024	BUY	$52.16 - $64.19 $135,563 - $166,829	2,599 Added 12.7%	23,064 $1.45 Million
Q3 2023 Nov 01, 2023	BUY	$57.77 - $65.93 $37,666 - $42,986	652 Added 3.29%	20,465 $1.18 Million
Q2 2023 Jul 31, 2023	SELL	$60.95 - $75.51 $38,825 - $48,099	-637 Reduced 3.11%	19,813 $1.23 Million
Q1 2023 May 02, 2023	BUY	$70.23 - $86.01 $90,807 - $111,210	1,293 Added 6.75%	20,450 $1.48 Million

Q4 2022 Feb 06, 2023	BUY	$67.18 - $84.11 $99,023 - $123,978	1,474 Added 8.34%	19,157 $1.54 Million
Q3 2022 Nov 02, 2022	BUY	$66.18 - $82.86 $9,132 - $11,434	138 Added 0.79%	17,683 $1.18 Million
Q2 2022 Aug 09, 2022	BUY	$66.18 - $83.18 $61,084 - $76,775	923 Added 5.55%	17,545 $1.33 Million
Q1 2022 Apr 29, 2022	BUY	$66.02 - $79.71 $304,616 - $367,781	4,614 Added 38.42%	16,622 $1.32 Million
Q4 2021 Feb 03, 2022	SELL	$63.34 - $74.11 $327,721 - $383,445	-5,174 Reduced 30.11%	12,008 $881,000
Q3 2021 Nov 05, 2021	BUY	$68.67 - $84.02 $124,842 - $152,748	1,818 Added 11.83%	17,182 $1.18 Million
Q2 2021 Aug 06, 2021	BUY	$79.87 - $87.53 $57,985 - $63,546	726 Added 4.96%	15,364 $1.29 Million
Q1 2021 May 03, 2021	BUY	$76.02 - $100.5 $117,222 - $154,971	1,542 Added 11.77%	14,638 $1.19 Million
Q4 2020 Feb 04, 2021	BUY	$80.74 - $97.7 $46,667 - $56,470	578 Added 4.62%	13,096 $1.14 Million
Q3 2020 Nov 02, 2020	BUY	$85.07 - $109.69 $234,112 - $301,866	2,752 Added 28.18%	12,518 $1.12 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $43,783 - $59,577	693 Added 7.64%	9,766 $715,000
Q4 2019 Jan 31, 2020	SELL	$73.04 - $95.72 $11,248 - $14,740	-154 Reduced 1.67%	9,073 $792,000
Q3 2019 Nov 04, 2019	BUY	$72.82 - $86.52 $38,667 - $45,942	531 Added 6.11%	9,227 $685,000
Q2 2019 Jul 24, 2019	SELL	$73.52 - $88.7 $882 - $1,064	-12 Reduced 0.14%	8,696 $739,000
Q1 2019 Apr 26, 2019	BUY	$63.56 - $88.17 $61,081 - $84,731	961 Added 12.4%	8,708 $749,000
Q4 2018 Feb 05, 2019	BUY	$58.5 - $69.94 $10,530 - $12,589	180 Added 2.38%	7,747 $493,000
Q3 2018 Nov 01, 2018	BUY	$61.75 - $74.23 $28,405 - $34,145	460 Added 6.47%	7,567 $523,000
Q1 2018 May 02, 2018	BUY	$83.06 - $100.98 $158,727 - $192,972	1,911 Added 36.78%	7,107 $592,000
Q4 2017 Feb 06, 2018	SELL	$93.56 - $116.6 $2.39 Million - $2.98 Million	-25,530 Reduced 83.09%	5,196 $492,000
Q3 2017 Nov 02, 2017	BUY	$109.15 - $138.27 $3.35 Million - $4.25 Million	30,726	30,726 $3.59 Million

Others Institutions Holding INCY

# of Institutions

618

Shares Held

215M

Call Options Held

366K

Put Options Held

445K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $12.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Incyte Corp Transaction History